TCT 287: Variation in the Utilization of Coronary Physiology Among Those Undergoing PCI in Michigan – Insights from the BMC2

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Cordis Corporation, a Johnson & Johnson company; CSI; Shockwave; Opsens; Abbott Vascular